Cargando…

Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India – Authors' reply

Detalles Bibliográficos
Autores principales: Thiruvengadam, Ramachandran, Awasthi, Amit, Bhatnagar, Shinjini, Garg, Pramod Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942565/
https://www.ncbi.nlm.nih.gov/pubmed/35338864
http://dx.doi.org/10.1016/S1473-3099(22)00120-7
_version_ 1784673330593267712
author Thiruvengadam, Ramachandran
Awasthi, Amit
Bhatnagar, Shinjini
Garg, Pramod Kumar
author_facet Thiruvengadam, Ramachandran
Awasthi, Amit
Bhatnagar, Shinjini
Garg, Pramod Kumar
author_sort Thiruvengadam, Ramachandran
collection PubMed
description
format Online
Article
Text
id pubmed-8942565
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89425652022-03-24 Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India – Authors' reply Thiruvengadam, Ramachandran Awasthi, Amit Bhatnagar, Shinjini Garg, Pramod Kumar Lancet Infect Dis Correspondence Elsevier Ltd. 2022-04 2022-03-23 /pmc/articles/PMC8942565/ /pubmed/35338864 http://dx.doi.org/10.1016/S1473-3099(22)00120-7 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Thiruvengadam, Ramachandran
Awasthi, Amit
Bhatnagar, Shinjini
Garg, Pramod Kumar
Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India – Authors' reply
title Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India – Authors' reply
title_full Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India – Authors' reply
title_fullStr Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India – Authors' reply
title_full_unstemmed Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India – Authors' reply
title_short Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India – Authors' reply
title_sort effectiveness of chadox1 ncov-19 vaccine during the delta (b.1.617.2) variant surge in india – authors' reply
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942565/
https://www.ncbi.nlm.nih.gov/pubmed/35338864
http://dx.doi.org/10.1016/S1473-3099(22)00120-7
work_keys_str_mv AT thiruvengadamramachandran effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindiaauthorsreply
AT awasthiamit effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindiaauthorsreply
AT bhatnagarshinjini effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindiaauthorsreply
AT gargpramodkumar effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindiaauthorsreply
AT effectivenessofchadox1ncov19vaccineduringthedeltab16172variantsurgeinindiaauthorsreply